STUDY OF ELISA TEST-SYSTEMS OF DIFFERENT FORMATS FOR DETECTION OF MEASLES VIRUS SPECIFIC IgM IN DIFFERENT GEOGRAPHIC ZONES
- Authors: Bichurina M.A.1, Zheleznova N.V.1, Lavrentieva I.N.1, Antipova A.Y.1, Kulyashova L.B.1, Totolian A.A.1
-
Affiliations:
- St. Petersburg Pasteur Institute,
- Issue: Vol 8, No 2 (2018)
- Pages: 230-234
- Section: SHORT COMMUNICATIONS
- Submitted: 10.09.2018
- Accepted: 10.09.2018
- Published: 10.09.2018
- URL: https://iimmun.ru/iimm/article/view/743
- DOI: https://doi.org/10.15789/2220-7619-2018-2-230-234
- ID: 743
Cite item
Full Text
Abstract
Detection of the measles virus (MV) specific IgM antibodies in blood serum of patients is considered to be the main standard for the laboratory confirmation of measles diagnosis, the test being acknowledged by WHO. As it was demonstrated earlier the specific IgM antibodies as the marker of the acute MV infection were detected in 97.2–100% of blood serum samples from patients using the ELISA test-systems of the “capture” format (Microimmun Ltd. and Vector Best). In case when the ELISA test-system of the “indirect” format (Siemens, Germany) was used only 63.9% of these sera turned to be IgM positive. And on the contrary using the “indirect” format ELISA test-system Euroimmun, Germany, for detection of the MV specific IgM the false positive results were obtained.
The aim of the study was the comparative evaluation of the different format ELISA test-systems used for the detection of the MV specific IgM antibodies in blood sera of patients and healthy adults collected in different geographic zones.
Materials and methods. In total 108 serum specimens collected in 2015–2017 were studied: from healthy adult Guineans, residents of the Republic of Guinea (RG); patients aged 1–70 with the initial “infectious mononucleosis”, “infectious cytomegalovirus” and “rubella” diagnosis and taken from the bank of sera in the Subnational Measles/Rubella laboratory, StP Measles/Rubella RC in NWFR. The MV specific IgM antibodies were detected using the commercial ELISA test-systems “VectoMeasles-IgM” (Vector-Best, Russia) (“capture” format) and “Anti-Measles Virus ELISA IgM (NP)” (Euroimmun Medizinische Labordiagnostik AG, Germany) («indirect» format). The specific Epshtein-Barr Virus (EBV) IgM and IgG antibodies were detected with the commercial ELISA test-systems «DS-ELISA-anti-EBV-VCA-M», «DS-ELISA-anti-EBV-EA-G» and «DS-ELISA-anti-EBV-NA-G» (“Diagnostic Systems”, Russia).
Results and discussion. The MV specific IgM antibodies were not revealed in the total of 108 blood serum samples from the healthy adults and patients, residents of the Russia and of the RG, with the “capture” format “VectoMeasles-IgM” ELISA test-system. The absence of the acute MV infection was also confirmed by the high measles immunity level (i.e. IgG MV antibodies titers) as well as by detection of the IgG antibodies of high avidity. At the same time in 6 of 108 total sera (5.5%) IgM MV antibodies were detected with the «indirect» format ELISA test system Euroimmun, Germany. In these 6 sera the EBV specific antibodies were also evidenced. The results obtained demonstrate the nonspecific reaction due to the possible reactivity with anti-EBV antibodies. Besides this the different percentage of the false positive reactions in sera from healthy adults, residents of the RG and residents of Russia was determined — 8.5±4.0% and 3.2±2.2% correspondently. Thus the preliminary results, and to get the final results for general conclusions increase of the total amount of the clinical specimens under studying is of extremely importance.
About the authors
M. A. Bichurina
St. Petersburg Pasteur Institute,
Email: fake@neicon.ru
PhD, MD (Medicine), Head of the Laboratory of Etiology and Control of Viral Infections, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation
РоссияN. V. Zheleznova
St. Petersburg Pasteur Institute,
Email: fake@neicon.ru
PhD (Biology), Leading Researcher, Laboratory of Viral Hepatitis, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation
РоссияI. N. Lavrentieva
St. Petersburg Pasteur Institute,
Email: fake@neicon.ru
PhD, MD (Medicine), Head of the Laboratory of experimental virology, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation
РоссияA. Yu. Antipova
St. Petersburg Pasteur Institute,
Author for correspondence.
Email: anti130403@mail.ru
PhD (Biology), Senior Researcher, Laboratory of experimental virology, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation
197101, Russian Federation, St. Petersburg, Mira str., 14
Phone: +7 (812) 232-94-11 (office). Fax: +7 (812) 233-20-92
РоссияL. B. Kulyashova
St. Petersburg Pasteur Institute,
Email: fake@neicon.ru
PhD (Medicine), Leading Researcher, Laboratory of Identification of Pathogens, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation
РоссияAreg A. Totolian
St. Petersburg Pasteur Institute,
Email: fake@neicon.ru
RAS Full Member, PhD, MD (Medicine), Professor, Head of the Laboratory of Molecular Immunology, Director, St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation
РоссияReferences
- Мамаева Т.А., Наумова М.А., Железнова Н.В., Липская Г.Ю., Mulders S.M., Featherstone D.A. Оценка коммерческих тест-систем ИФА разного формата для определения уровня специфических IgM и IgG в сыворотках больных корью // Вопросы вирусологии. 2013. Т. 58, № 5. С. 43–48. [Mamaeva T.A., Naumova M.A., Zheleznova N.V., Lipskaya G.Y., Mulders M., Featherstone D.A. Estimation of the commercial elisa test-systems of different formats to detect specific IgM and IgG in the measles patients sera. Voprosy virusologii = Problems of Virology, 2013, vol. 58, no. 5, pp. 43–48. (In Russ.)]
- Попова А.Ю., Бичурина М.А., Лаврентьева И.Н., Железнова Н.В., Антипова А.Ю., Щербакова С.А., Буаро М.Й., Тотолян А.А. Изучение уровня иммунитета к вирусу кори в отдельных группах населения Гвинейской Республики в рамках глобальной программы элиминации кори. Сообщение 2 // Инфекция и иммунитет. 2017. Т. 7, № 1. С. 79–84. [Popova A.Y., Bichurina M.A., Lavrentyeva I.N., Zheleznova N.V., Antipova A.Y., Shcherbakova S.A., Boiro M.Y., Totolian A.A. Measles virus immunity level study in particular population groups of the republic of guinea within the framework of global measles elimination program. Report 2. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2017, vol. 7, no. 1, pp. 79–84. doi: 10.15789/2220-7619-2017-1-79-84 (In Russ.)]
- Getahun M., Beyene B., Ademe A., Teshome B., Tefera M., Asha A., Afework A., Hailemariyam Y., Assefa E., Gallagher K. Epidemiology of laboratory confirmed measles virus cases in Amhara Regional State of Ethiopia, 2004–2014. BMC Infect. Dis., 2016, vol. 16 (133), 7 p. doi: 10.1186/s12879-016-1457-7
- Parent du Chatelet I., Floret D., Antona D., Levy-Bruhl D. Measles resurgence in France in 2008, a preliminary report. Euro Surveill., 2009, vol. 14, iss. 6: 19118. doi: 10.2807/ese.14.06.19118-en
- Suk J.E., Jimenez A.P., Kourouma M., Derrough T., Balde M., Honomou P., Kolie N., Mamadi O., Tamba K., Lamah K., Loua A., Mollet T., Lamah M., Camara A., Prikazsky V. Post-Ebola measles outbreak in Lola, Guinea, January-June 2015. Emerg. Infect. Dis., 2016, vol. 22, no. 6, pp. 1106–1108. doi: 10.3201/eid2206.151652
- World Health Organization. Manual for the laboratory diagnosis of measles and rubella virus infection. 2006, Geneva, Switzerland. URL: http://www.who.int/ihr/elibrary/manual_diagn_lab_mea_rub_en.pdf (18.05.2018)
- World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2016 global summary. URL: http://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%5B%5D=GIN&commit=OK (18.05.2018)